Chemoimmunotherapy for oesophageal cancer: the next step on the path towards better outcomes
Eur J Cardiothorac Surg
.
2022 Aug 3;62(1):ezac395.
doi: 10.1093/ejcts/ezac395.
Author
Jeffrey A Hagen
1
Affiliation
1
Thoracic Surgery, Sanger Heart and Vascular Institute, Atrium Health, Charlotte, NC, USA.
PMID:
35924975
DOI:
10.1093/ejcts/ezac395
No abstract available
Keywords:
Immunotherapy; Neoadjuvant therapy; Oesophageal cancer.
Publication types
Editorial
Comment
MeSH terms
Chemoradiotherapy
Esophageal Neoplasms* / therapy
Esophageal Squamous Cell Carcinoma*
Humans
Neoadjuvant Therapy